The Modulation of Inflammatory Gene Expression by Lipids: Mediation through Toll-like Receptors

참고문헌 (Reference)

1 Hamann, L, "frequent toll-like receptor (TLR)-2 polymorphism is a risk factor for coronary restenosis." 83 : 478-485, 2005

2 Kawai, T, "Unresponsiveness of MyD88-deficient mice to endotoxin." 11 : 115-122, 1999

3 Hashimoto, M, "Treponemal phospholipids inhibit innate immune responses induced by pathogen-associated molecular patterns." 278 : 2003

4 Frantz, S, "Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium." 104 : 271-280, 1999

5 Sato, S, "Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptorassociated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFNregulatory factor-3, in the Toll-like receptor signaling." 171 : 4304-4310, 2003

6 Akira, S, "Toll-like receptors: critical proteins linking innate and acquired immunity" 2 : 675-680, 2001

7 Aderem, A, "Toll-like receptors in the induction of the innate immune response" 406 : 782-787, 2000

8 Miller, Y. I, "Toll-like receptor 4-dependent and - independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages." 25 : 1213-1219, 2005

9 Kiechl, S, "Toll-like receptor 4 polymorphisms and atherogenesis." 347 : 185-192, 2002

10 Kolek, M. J, "Toll-like receptor 4 gene Asp299Gly polymorphism is associated with reductions in vascular inflammation, angiographic coronary artery disease, and clinical diabetes." 148 : 1034-1040, 2004

11 Jiang, Z, "Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFNbeta" 101 : 3533-3538, 2004

12 Joosten, L. A, "Toll-like receptor 2 pathway drives streptococcal cell wall-induced joint inflammation: critical role of myeloid differentiation factor 88." 171 : 6145-6153, 2003

13 Byrd-Leifer, C. A, "The role of MyD88 and TLR4 in the LPS-mimetic activity of Taxol." 31 : 2448-2457, 2001

14 Ozinsky, A, "The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors." 97 : 2000

15 Haziot, A, "The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphati-dylinositol linkage." 141 : 547-552, 1988

16 Ninomiya-Tsuji, J, "The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway." 398 : 252-256, 1999

17 Muzio, M, "The human toll signaling pathway: divergence of nuclear factor kappaB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6)." 187 : 2097-2101, 1998

18 Okamura, Y, "The extra domain A of fibronectin activates Toll-like receptor 4." 276 : 2001

19 Wen, L, "The effect of innate immunity on autoimmune diabetes and the expression of Toll-like receptors on pancreatic islets." 172 : 3173-3180, 2004

20 Endres, S, "The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells." 320 : 265-271, 1989

21 Horng, T, "The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors." 420 : 329-333, 2002

22 Medzhitov, R, "The Toll receptor family and microbial recognition." 8 : 452-456, 2000

23 Yamamoto, M, "TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway." 4 : 1144-1150, 2003

24 Toshchakov, V, "TLR4, but not TLR2, mediates IFN-betainduced STAT1alpha/beta-dependent gene expression in macrophages" 3 : 392-398, 2002

25 Bin, L. H, "TIRP, a novel Toll/interleukin-1 receptor (TIR) domain-containing adapter protein involved in TIR signaling." 278 : 2003

26 Horng, T, "TIRAP: an adapter molecule in the Toll signaling pathway." 2 : 835-841, 2001

27 Oshiumi, H, "TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to toll-like receptor 4 TICAM-1 that induces interferon-beta." 278 : 2003

28 Oshiumi, H, "TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction." 4 : 161-167, 2003

29 Leitinger, N, "Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils." 96 : 1999

30 Krauss, J. H, "Structural analysis of the nontoxic lipid A of Rhodobacter capsulatus 37b4." 180 : 519-526, 1989

31 Werner, S. L, "Stimulus specificity of gene expression programs determined by temporal control of IKK activity." 309 : 1857-1861, 2005

32 Liu, Z. Q, "Staphylococcal peptidoglycans induce arthritis." 3 : 375-380, 2001

33 Walton, K. A, "Specific phospholipid oxidation products inhibit ligand activation of toll-like receptors 4 and 2" 23 : 1197-1203, 2003

34 Suzuki, N, "Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4." 416 : 750-756, 2002

35 Zheng, S. L, "Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the cancer prostate in Sweden study." 64 : 2918-2922, 2004

36 Chen, Y. C, "Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer" 65 : 2005

37 Sun, J, "Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk." 97 : 525-532, 2005

38 Lee, J. Y, "Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4." 276 : 2001

39 Lee, J. Y, "Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1." 279 : 2004

40 Kersten, S, "Roles of PPARs in health and disease." 405 : 421-424, 2000

41 Yamamoto, M, "Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway." 301 : 640-643, 2003

42 Serhan, C. N, "Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals." 196 : 1025-1037, 2002

43 Serhan, C. N, "Resolution of inflammation: the beginning programs the end." 6 : 1191-1197, 2005

44 Leemans, J. C, "Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney." 115 : 2894-2903, 2005

45 Bonazzi, A, "Regulation of cyclooxygenase-2 by hypoxia and peroxisome proliferators in the corneal epithelium." 275 : 2837-2844, 2000

46 Oyama, J, "Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice." 109 : 784-789, 2004

47 Bjorkbacka, H, "Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways" 10 : 416-421, 2004

48 Schnare, M, "Recognition of CpG DNA is mediated by signaling pathways dependent on the adaptor protein MyD88." 10 : 1139-1142, 2000

49 Lee, J. Y, "Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3- kinase/AKT by saturated and polyunsaturated fatty acids." 278 : 2003

50 Brentano, F, "RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3." 52 : 2656-2665, 2005

51 Meylan, E, "RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation." 5 : 503-507, 2004

52 Bochkov, V. N., "Protective role of phospholipid oxidation products overexpression in endotoxin-induced tissue damage." 419 : 77-81, 2002

53 Stulnig, T. M, "Polyunsaturated eicosapentaenoic acid displaces proteins from membrane rafts by altering raft lipid composition." 276 : 2001

54 Torok, H. P, "Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis." 112 : 85-91, 2004

55 Wang, P. Y, "Phosphatidylinositides bind to plasma membrane CD14 and can prevent monocyte activation by bacterial lipopolysaccharide." 273 : 1998

56 Meade, E. A, "Peroxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells." 274 : 8328-8334, 1999

57 Eligini, S, "Oxidized low density lipoprotein suppresses expression of inducible cyclooxygenase in human macrophages." 19 : 1719-1725, 1999

58 Chawla, A, "Nuclear receptors and lipid physiology: opening the X-files" 294 : 1866-1870, 2001

59 Asea, A, "Novel signal transduction pathway utilized" 277 : 2002

60 Netea, M. G, "Non-LPS components of Chlamydia pneumoniae stimulate cytokine production through Toll-like receptor 2-dependent pathways." 32 : 1188-1195, 2002

61 Burns, K, "MyD88, an adapter protein involved in interleukin-1 signaling" 273 : 1998

62 Medzhitov, R, "MyD88 is an adaptor protein in the hToll/IL- 1 receptor family signaling pathways." 2 : 253-258, 1998

63 Mullick, A. E, "Modulation of atherosclerosis in mice by Toll-like receptor 2." 115 : 3149-3156, 2005

64 Miller, Y. I, "Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells." 278 : 1561-1568, 2003

65 Triantafilou, M, "Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharideinduced cell activation." 115 : 2603-2611, 2002

66 Fitzgerald, K. A, "Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction." 413 : 78-83, 2001

67 Shimazu, R, "MD-2, a molecule that confers lipopolysaccharide MD-2, a molecule that confers lipopolysaccharide" 189 : 1777-1782, 1999

68 Daemen, T, "Liposomal phosphatidylserine inhibits tumor cytotoxicity of liver dependent pathway but not toll/IL-1 receptor domain-containing macrophages induced by muramyl dipeptide and lipopolysaccharide" 1285 : 219-228, 1996

69 Seki, E, "Lipopolysaccharide-induced IL-18 secretion from murine Kupffer cells independently of myeloid differentiationfactor 88 that is critically involved in induction of production of IL-12 and IL-1beta." 166 : 2651-2657, 2001

70 da Silva Correia, J, "Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex." 276 : 2001

71 Jiang, Q, "Lipopolysaccharide induces physical proximity between CD14 and toll-like receptor 4 (TLR4) prior to nuclear translocation of NF-kappa B." 165 : 3541-3544, 2000

72 Lu, M, "Lipopolysaccharide deacylation by an endogenous lipase controls innate antibody responses to Gram-negative bacteria." 6 : 989-994, 2005

73 Pfeiffer, A, "Lipopolysaccharide and ceramide docking to CD14 provokes ligand-specific receptor clustering in rafts." 31 : 3153-3164, 2001

74 Kitchens, R. L, "Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14- mediated pathway." 176 : 485-494, 1992

75 Saitoh, S, "Lipid A antagonist, lipid IVa, is distinct from lipid A in interaction with Toll-like receptor 4 (TLR4)-MD-2 and ligand-induced TLR4 oligomerization." 16 : 961-969, 2004

76 Michelsen, K. S, "Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E." 101 : 2004

77 Fitzgerald, K. A, "LPS-TLR4 Signaling to IRF-3/7 and NF-κB Involves the Toll Adapters TRAM and TRIF." 198 : 1043-1055, 2003

78 Zeyda, M, "LAT displacement from lipid rafts as a molecular mechanism for the inhibition of T cell signaling by polyunsaturated fatty acids." 277 : 2002

79 Deng, G. M, "Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis." 5 : 702-705, 1999

80 Zhang, H, "Integrin-nucleated Toll-like receptor (TLR) dimerization reveals subcellular targeting of TLRs and distinct mechanisms of TLR4 activation and signaling." 532 : 171-176, 2002

81 Mandell, L, "Intact gram-negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus bacteria activate innate immunity via toll-like receptor 2 but not toll-like receptor 4." 72 : 6446-6454, 2004

82 Medzhitov, R, "Innate immunity: the virtues of a nonclonal system of recognition." 91 : 295-298, 1997

83 Yeh, M, "Increased transcription of IL-8 in endothelial cells is differentially regulated by TNF-alpha and oxidized phospholipids." 21 : 1585-1591, 2001

84 Hacker, H, "Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6." 192 : 595-600, 2000

85 Forman, B. M, "Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta." 94 : 4312-4317, 1997

86 Gobert, A. P, "Helicobacter pylori heat shock protein 60 mediates interleukin-6 production by macrophages via a toll-like 88-independent mechanism" 279 : 245-250, 2004

87 Krey, G, "Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferatoractivated receptors by coactivator-dependent receptor ligand assay." 11 : 779-791, 1997

88 Hwang, D, "Fatty acids and immune responses--a new perspective in searching for clues to mechanism." 20 : 431-456, 2000

89 Clarke, S. D, "Fatty acid regulation of gene expression: a genomic explanation for the benefits of the mediterranean diet." 967 : 283-298, 2002

90 Edfeldt, K, "Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation." 105 : 1158-1161, 2002

91 Seibl, R, "Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium." 162 : 1221-1227, 2003

92 Subbanagounder, G, "Epoxyisoprostane and epoxycyclopentenone phospholipids regulate monocyte chemotactic protein-1 and interleukin-8 synthesis. Formation of these oxidized phospholipids in response to interleukin-1beta." 277 : 7271-7281, 2002

93 Kaisho, T, "Endotoxin-induced maturation of MyD88-deficient dendritic cells." 166 : 5688-5694, 2001

94 Gao, B, "Endotoxin contamination in recombinant human heat shock protein 70 (Hsp70) preparation is responsible for the induction of tumor necrosis factor alpha release by murine macrophages." 278 : 174-179, 2003

95 Shi, W, "Endothelial responses to oxidized lipoproteins determine genetic susceptibility to atherosclerosis in mice." 102 : 75-81, 2000

96 Vabulas, R. M, "Endocytosed HSP60s use tolllike receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells." 276 : 2001

97 Minoretti, P, "Effect of the functional toll-like receptor 4 Asp299Gly polymorphism on susceptibility to late-onset Alzheimer’s disease." 391 : 147-149, 2006

98 Takeuchi, O, "Discrimination of bacterial lipoproteins by Tolllike receptor 6." 13 : 933-940, 2001

99 Kutuzova, G. D, "Diphosphoryl lipid A from Rhodobacter sphaeroides blocks the binding and internalization of lipopolysaccharide in RAW 264.7 cells." 167 : 482-489, 2001

100 Lee, J. Y, "Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids." 44 : 479-486, 2003

101 Cario, E, "Differential alteration in differentially intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease." 68 : 7010-7017, 2000

102 Endres, S, "Dietary supplementation with n-3 fatty acids suppresses interleukin-2 production and mononuclear cell proliferation." 54 : 599-603, 1993

103 Munford, R. S, "Detoxification of bacterial lipopolysaccharides (endotoxins) by a human neutrophil enzyme." 234 : 203-205, 1986

104 Franchimont, D, "Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn’s disease and ulcerative colitis." 53 : 987-992, 2004

105 Poltorak, A, "Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene." 282 : 2085-2088, 1998

106 Juge-Aubry, C, "DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. Importance of the 5′-flanking region." 272 : 1997

107 Takeuchi, O, "Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins." 169 : 10-14, 2002

108 Ohashi, K, "Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex." 164 : 558-561, 2000

109 Yamamoto, M, "Cutting edge: a novel Toll/IL-1 receptor domaincontaining adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling." 169 : 6668-6672, 2002

110 Gohda, J, "Cutting edge: TNFR-associated factor (TRAF) 6 is essential for MyD88-dependent pathway but not toll/IL-1 receptor domain-containing adaptor-inducing IFN-beta (TRIF)-dependent pathway in TLR signaling." 173 : 2913-2917, 2004

111 Kliewer, S. A, "Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors." 358 : 771-774, 1992

112 Wright, S. D, "CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein." 249 : 1431-1433, 1990

113 Zare, F, "Arthritogenic properties of doublestranded (viral) RNA." 172 : 5656-5663, 2004

114 Covert, M. W, "Achieving stability of lipopolysaccharide-induced NF-kappaB activation." 309 : 1854-1857, 2005

115 Hawn, T. R, "A stop codon polymorphism of Toll-like receptor 5 is associated with resistance to systemic lupus erythematosus." 102 : 2005

116 Medzhitov, R, "A human homologue of the Drosophila Toll protein signals activation of adaptive immunity." 388 : 394-397, 1997

117 Fitzgerald, K. A, "(2003a) IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway." 4 : 491-496, 2003